Search Trials

Order


Status


157 results


Recruiting

Start date: Sept. 1, 2020

An initial single-dose PK study will be carried out. Forty-two children (n=21 per dose) will be randomized to receive approximately 10.9 mg·kg-1·d-1 of PMO or to receive approximately 18.2 mg·kg-1·d-1 … Read More

BCM Role: Lead Sponsor

Recruiting

Start date: Aug. 25, 2020

Approximately 5,000 children die from septic shock each year in the United States (US); thousands more die worldwide. Most children admitted with sepsis receive initial resuscitation in an emergency department … Read More

BCM Role: Collaborator

Recruiting

Start date: Aug. 6, 2020

The ESTHI Trial is a multi-center randomized controlled trial (RCT) comparing endoscopic third ventriculostomy with choroid plexus cauterization (ETV+CPC) and shunt in infants with hydrocephalus. The study will leverage the … Read More

BCM Role: Collaborator

Recruiting

Start date: Aug. 3, 2020

The primary objective of this phase 1, first in man trial is to determine the safety, toxicity, and feasibility of delivering autologous dendritic cells (DCs) loaded with pancreatic adenocarcinoma lysate … Read More

BCM Role: Lead Sponsor

Recruiting

Start date: July 20, 2020

Adolescents are disproportionately affected by sexually transmitted infections (STIs). The STI epidemic among youth is a national public health priority as noted in the Healthy People 2020 objectives, which specifically … Read More

BCM Role: Collaborator

Recruiting

Start date: July 9, 2020

To make the CLL1-CD28 chimeric antigen receptor T cells, the investigators will collect the patient's blood and stimulate them with growth factors to make the cells grow. To get the … Read More

BCM Role: Lead Sponsor

Recruiting

Start date: July 2, 2020

Resection of gastrointestinal neoplastic lesions at an early stage has been associated with improved clinical outcomes. While surgery has been traditionally performed for the resection of these precancerous or cancerous … Read More

BCM Role: Lead Sponsor

Recruiting

Start date: May 8, 2020

This pilot randomized placebo controlled study will include 60 men (30 treatment and 30 placebo). ARM 1 will take flibanserin 100mg orally every night and ARM 2 will take a … Read More


Recruiting

Start date: April 20, 2020

Study design: A placebo-controlled adaptive multi-center randomized controlled trial. Study population: High risk HCW with direct patient contacts, defined as physician assistants, respiratory therapists, nurses, physicians or other HCWs working … Read More

BCM Role: Collaborator

Recruiting

Start date: April 15, 2020

Earlier, a healthy donor provided blood to make ANCHOR cells in the laboratory. These cells were grown and frozen for later use. To make the ANCHOR cells, the investigators took … Read More

BCM Role: Lead Sponsor